There are plenty of opportunities to invest in healthcare stocks, as there are thousands of companies, ranging from big and well-established pharmaceuticals...
Keep Reading →
March 14 - Hedge Funds, News - Comments
Investing in cheap stocks can be risky and inexperienced investors are usually advised to stay clear of them, even though many new investors go straight...
Keep Reading →
March 5 - Hedge Funds, News - Comments
Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that...
Keep Reading →
September 1 - Lists, News - Comments
1. U.S. Stock Market: “Stocks rose on Wall Street on Thursday, capping a wave of declines in major world equity markets triggered by uncertainty...
Keep Reading →
May 18 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk...
Keep Reading →
October 8 - Hedge Funds, News - Comments
As we noted last week, the close of the third quarter and the start of the final quarter of the year is when volume really starts to pick up in wider...
Keep Reading →
September 13 - News, Stock Analysis - Comments
When it comes to the risk-reward ratio, there are very few sectors which can match up to healthcare. The healthcare universe boasts of several companies...
Keep Reading →
March 24 - Hedge Funds, News - Comments
Peter Kolchinsky founded RA Capital Management in 2001 and focuses mainly on healthcare stocks. One of the few hedge fund managers who actually holds...
Keep Reading →
February 25 - Hedge Funds, News - Comments
Peter Kolchinsky‘s RA Capital Management recently filed its 13F with the SEC for the reporting period of June 30. Peter Kolchinsky started RA Capital...
Keep Reading →
August 15 - Hedge Fund Analysis, Hedge Funds, News - Comments
Mere months after closing its previously held stake in the company, Steve Cohen’s Point72 Asset Management appears to be more bullish than ever on Achillion...
Keep Reading →
May 31 - Hedge Funds, News - Comments
James E. Flynn of Deerfield Management, recently disclosed a stake of 1.27 million shares in Steadymed Ltd (NASDAQ:STDY). Of this stake, 737,555 shares...
Keep Reading →
March 27 - Hedge Funds, News - Comments
It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position...
Keep Reading →
January 21 - Hedge Funds, News - Comments
CIG Wireless Corp (OTCBB:CIGW), an operator of wireless and broadcast communication towers in the United States, has issued approximately 1.25 million...
Keep Reading →
October 2 - Hedge Funds, News - Comments
RA Capital Management has continued the sale of Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares. In a recent wave of reductions, the fund has dumped...
Keep Reading →
September 29 - Hedge Funds, News - Comments
RA Capital Management, managed by Peter Kolchinsky, continues to unload its stake in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN). In a new filing with...
Keep Reading →
September 24 - Hedge Funds, News - Comments
For those who have some extra cash lying around and would prefer to make it work for them instead of just receiving low interest rates from their savings...
Keep Reading →
September 23 - Lists - Comments
Peter Kolchinsky‘s RA Capital Management, in a new filing with the Securities and Exchange Commission, has disclosed the sale of around 1.70 million...
Keep Reading →
September 12 - Hedge Funds, News - Comments
In a new filing with the U.S. Securities and Exchange Commission, RA Capital Management, managed by Peter Kolchinsky, has disclosed holding an 18.1% passive...
Keep Reading →
September 4 - Hedge Funds, News - Comments
Manchester United Divides Hedge Funds’ Loyalties (WSJ) Some of Europe’s most powerful hedge fund managers are sharply divided on the outlook...
Keep Reading →
August 28 - Hedge Funds - Comments
RA Capital Management, led by Peter Kolchinsky, disclosed in a newly amended filing with the U.S. Securities and Exchange Commission that it further reduced...
Keep Reading →
August 28 - Hedge Funds, News - Comments
RA Capital Management, managed by Peter Kolchinsky, has sold 800,000 shares of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN) in two transactions for about...
Keep Reading →
June 25 - Hedge Funds, News - Comments
Peter Kolchinsky‘s Ra Capital Management disclosed a new position in Enanta Pharmaceuticals Inc (NASDAQ:ENTA). According to a 13G filing, the...
Keep Reading →
April 2 - Hedge Funds, News - Comments
Peter Kolchinsky and Ra Capital Management are betting big on Xencor Inc (NASDAQ:XNCR). In a recent filing with the Securities and Exchange Commission...
Keep Reading →
December 11 - Hedge Funds, News - Comments
Peter Kolchinsky‘s hedge fund, Ra Capital Management disclosed upping its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) some more....
Keep Reading →
November 22 - Hedge Funds, News - Comments
Peter Kolchinsky‘s, RA Capital Management solidified its position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) even more today. This time,...
Keep Reading →
November 13 - Hedge Funds, News - Comments
Since the beginning of November, Peter Kolchinsky‘s RA Capital Management has informed the U.S. Securities and Exchange Commission that it’...
Keep Reading →
November 12 - Hedge Funds, News - Comments
Peter Kolchinsky and his hedge fund, RA Capital Management, boosted their position in Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) to 21.2%, a filing...
Keep Reading →
November 1 - Hedge Funds, News - Comments
Peter Kolchinsky, Achillion Pharmaceuticals: This afternoon, Peter Kolchinsky and his hedge fund, RA Capital Management, strengthened their position...
Keep Reading →
October 16 - Hedge Funds, News - Comments
Outerwall, Pandora, Achillion, hedge funds: It’s no secret that at Insider Monkey, we track hedge funds (discover why here). While a good portion...
Keep Reading →
October 11 - Hedge Funds, News - Comments
RA Capital, Achillion Pharmaceuticals: In a 13G filing with the SEC, Peter Kolchinsky‘s RA Capital disclosed that it owns nearly 15% of infectious...
Keep Reading →
October 4 - Hedge Funds, News - Comments
What’s a smart Dendreon Corporation (NASDAQ:DNDN) investor to do? To the average investor, there are tons of methods shareholders can use to monitor...
Keep Reading →
September 5 - News - Comments
What’s a smart InterMune Inc (NASDAQ:ITMN) investor to do? To many market players, hedge funds are perceived as delayed, old financial tools of...
Keep Reading →
September 3 - News - Comments
Is Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) a good investment? To the average investor, there are dozens of indicators market participants can use...
Keep Reading →
August 30 - News - Comments
In today’s marketplace, there are tons of gauges market participants can use to track their holdings. A duo of the most innovative are hedge fund and...
Keep Reading →
August 28 - News - Comments
Babe Ruth wasn’t afraid to swing for the fences. That’s how he became Major League Baseball’s home run king for decades. If you’...
Keep Reading →
July 15 - News - Comments
Hepatitis C, caused by the hepatitis C virus (HCV), is an infectious disease affecting the liver. An estimated 130 million-200 million people worldwide...
Keep Reading →
July 10 - News - Comments
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Keep Reading →
July 8 - News - Comments
Biotechnology’s a volatile sector that can intimidate many investors, but it’s also a landscape of stocks that can reward portfolios with...
Keep Reading →
June 17 - News - Comments
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) investors should pay attention to an increase in hedge fund interest in recent months. To most stock holders...
Keep Reading →
June 3 - News - Comments
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the...
Keep Reading →
April 27 - News - Comments
The Motley Fool’s annual April Fools’ Day joke this year focused on the “hugest bubble in history” that is set to explode. For...
Keep Reading →
April 6 - News - Comments
In the world of biotech investing, there are many companies to choose from. When the market is on a riding stride, investment in more speculative stocks...
Keep Reading →
April 3 - News - Comments
In the world of biotech stocks a lot of companies are starting to incorporate Hepatitis C treatments into their pipelines. Hepatitis C is starting to...
Keep Reading →
February 25 - News - Comments
When a company goes public, it’s usually cause for celebration for investors. But when companies return to the capital markets to do secondary offerings...
Keep Reading →
February 25 - News - Comments
It’s been a wet week for much of the U.S. Shareholders of several health care stocks probably feel like they have been soaked this week regardless...
Keep Reading →
February 22 - News - Comments
